Firefly Neuroscience CEO Issues Letter to Stockholders Following Closing of Merger and Listing on Nasdaq
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Aug 13 2024
0mins
Source: Newsfilter
Merger and Strategic Goals: Firefly Neuroscience has successfully completed its merger with WaveDancer, Inc., positioning itself to enhance patient outcomes in mental health through its AI-driven Brain Network Analytics (BNA™) technology, which aims for commercialization by 2025.
Collaborations and Future Plans: The company is focusing on partnerships with CNS drug developers and leveraging its extensive database to improve diagnostic accuracy and treatment pathways for brain health disorders, while also reducing costs and expediting drug development processes.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
